Shanghai No.1 Pharmacy Co.Ltd(600833) announcement: after receiving the notice from Bailian Group, the controlling shareholder of the company, the company was entrusted to undertake the task of providing epidemic prevention materials procurement services for the public. The company estimates that if the matter is implemented as planned, it will generate main business income of Tian Jin Bohai Chemical Co.Ltd(600800) million yuan, but the impact on profits is not clear. It is expected that this event will have a positive impact on the company’s operating revenue and net profit in 2022.